Subscribe: Ganfyd - Recent changes [en]
http://ganfyd.org/index.php?title=Special:Recentchanges&feed=rss&submit=Read
Preview: Ganfyd - Recent changes [en]

Ganfyd - Recent changes [en]



Track the most recent changes to the wiki in this feed.



Last Build Date: Fri, 20 Jan 2017 11:04:49 GMT

 



Guidance document

Fri, 20 Jan 2017 10:54:55 GMT

← Older revision Revision as of 10:54, 20 January 2017 Line 1: Line 1: {{QuotationBox|The Institute has always indicated that health professionals, when exercising their clinical judgement, should take its guidance fully into account; but that it does not override their responsibility for making appropriate decisions in the circumstances of the individual patient. This principle is important because even the best clinical guideline is unlikely to be able to accommodate more than around 80 per cent of patients for whom it has been developed.|[[NICE]]National Institute for Clinical Excellence. ''Response to the Report of the Bristol Royal Infirmary Inquiry''. 2001 (p8)}} {{QuotationBox|The Institute has always indicated that health professionals, when exercising their clinical judgement, should take its guidance fully into account; but that it does not override their responsibility for making appropriate decisions in the circumstances of the individual patient. This principle is important because even the best clinical guideline is unlikely to be able to accommodate more than around 80 per cent of patients for whom it has been developed.|[[NICE]]National Institute for Clinical Excellence. ''Response to the Report of the Bristol Royal Infirmary Inquiry''. 2001 (p8)}} There are many guidance documents (aka ''guidelines'', ''clinical guidelines'' ) for doctors, as well as ''protocols'' and [[Standard operating procedure|''standard operating procedures'']]. Some of these are linked to from specific ganfyd pages, and there are links to various other curated guidance links [[#Websites with links to clinical guidelines, protocols, etc.|below.]] There are many guidance documents (aka ''guidelines'', ''clinical guidelines'' ) for doctors, as well as ''protocols'' and [[Standard operating procedure|''standard operating procedures'']]. Some of these are linked to from specific ganfyd pages, and there are links to various other curated guidance links [[#Websites with links to clinical guidelines, protocols, etc.|below.]]  +  +The best guidelines are based on good quality evidence of e.g. treatment efficacy, and also incorporate disease specific insights into patients’ experiences, views, beliefs, and priorities, derived from qualitative research.[http://www.bmj.com/content/356/bmj.j80 Carroll C. Qualitative evidence synthesis to improve implementation of clinical guidelines. ''BMJ'' 2017;356.] There are various concerns about guidelines, for instance: There are various concerns about guidelines, for instance: [...]



Talk:Main Page

Fri, 20 Jan 2017 00:11:19 GMT

update on outages ← Older revision Revision as of 00:11, 20 January 2017 Line 170: Line 170: ::::::::::::::Still memory leak that fills it in days. Only reason no outage is that I have been able to reboot in good time over Xmas break. 07:42, 4 January 2017 (UTC) ::::::::::::::Still memory leak that fills it in days. Only reason no outage is that I have been able to reboot in good time over Xmas break. 07:42, 4 January 2017 (UTC) :::::::::::::::Memory leak continues. I managed to overload database connections forcing it to go into swap with just editing 25 odd pages fairly quickly with a template replacement at the same time it was being hit hard by an indexing bot that used up 700000k of memory in no time. Suspect some of my concurrent thread control has made a slight difference but it definitely does not like going into swap. [[User:Mlj|Mlj]] 20:57, 15 January 2017 (UTC) :::::::::::::::Memory leak continues. I managed to overload database connections forcing it to go into swap with just editing 25 odd pages fairly quickly with a template replacement at the same time it was being hit hard by an indexing bot that used up 700000k of memory in no time. Suspect some of my concurrent thread control has made a slight difference but it definitely does not like going into swap. [[User:Mlj|Mlj]] 20:57, 15 January 2017 (UTC)  +::::::::::::::::Went down about 30 minutes ago when I was in monitoring memory leak. Fails when swap greater than real memory and this suddenly happened when apparently server bombarded by over 400 httpd requests when it looked like we had 40% of memory still available - I thought I had limited number of apache processes to below this. Still there is an apache associated memory leak as I killed down apache first and this released very reasonable amount of memory, presumably in PHP as far as I can tell.Ah well00:11, 20 January 2017 (UTC) ==pubmed_caption_finder== ==pubmed_caption_finder== This has to be updated given PubMed's shift to https from tomorrow. From today it will generate https references BUT  the module still uses http call in php (as https call not recognised) to get all the info. This will no doubt change and give us message "Unable to contact Pubmed. This may be transient - please try again later. If this error recurs, please contact a ganfyd admin." If in due course I can enable php to do https I have version 20 of the module uploaded and ready to go and replace present version 21 (we were on version 19 before today) Cheers[[User:Mlj|Mlj]] 18:37, 26 September 2016 (BST) This has to be updated given PubMed's shift to https from tomorrow. From today it will generate https references BUT  the module still uses http call in php (as https call not recognised) to get all the info. This will no doubt change and give us message "Unable to contact Pubmed. This may be transient - please try again later. If this error recurs, please contact a ganfyd admin." If in due course I can enable php to do https I have version 20 of the module uploaded and ready to go and replace present version 21 (we were on version 19 before today) Cheers[[User:Mlj|Mlj]] 18:37, 26 September 2016 (BST) [...]



Abbreviations

Thu, 19 Jan 2017 12:18:06 GMT

S: SUDI link corrected.

← Older revision Revision as of 12:18, 19 January 2017
Line 734: Line 734:
*'''stat''' - immediatedly (Listed as official abbrevation in [http://www.medicinescomplete.com/mc/bnf/current/203970.htm|BNF])
*'''stat''' - immediatedly (Listed as official abbrevation in [http://www.medicinescomplete.com/mc/bnf/current/203970.htm|BNF])
*STI - [[Sexually transmitted infections|Sexually Transmitted Infection(s)]]
*STI - [[Sexually transmitted infections|Sexually Transmitted Infection(s)]]
-
*SUDI - [[Sudden Unexpected Death in infancy]]
+
*SUDI - [[Sudden unexpected death in infancy|Sudden Unexpected Death in Infancy]]
*SUI - Serious Untoward Incident
*SUI - Serious Untoward Incident
*SVAB - Safeguarding Vulnerable Adults Board
*SVAB - Safeguarding Vulnerable Adults Board



Cerumen

Thu, 19 Jan 2017 10:39:40 GMT

Moved the warning box ← Older revision Revision as of 10:39, 19 January 2017 (One intermediate revision not shown)Line 15: Line 15: == Clearing Impacted Cerumen == == Clearing Impacted Cerumen == -{{InterestBox|In countries where patients have direct access to medical care, without a primary care gatekeeper, it is more common for patients to present directly to ENT specialists, who spend much of their time extracting ear wax with a [[wax hook]], using the head mirror so rarely seen outside ENT clinics, but so beloved of cartoonists. }}This is a hazardous procedure, although not very, in most people.+{{InterestBox|In countries where patients have direct access to medical care, without a primary care gatekeeper, it is more common for patients to present directly to ENT specialists, who spend much of their time extracting ear wax with a [[wax hook]], using the head mirror so rarely seen outside ENT clinics, but so beloved of cartoonists. }}  +   +{{WarningBox|  +*Understand the technique  +*Examine the ear beforehand  +*Check the equipment (nozzle fixed properly etc)  +*Don't push too hard  +*Make a note}}  +   +This is a hazardous procedure, although not very, in most people. Traditionally wax has been softened with Sodium Bicarbonate or Olive Oil at [[fever|body temperature]] dripped into the ear (and the position with the canal pointing vertically upward maintained for 10 minutes) followed if necessary by syringing (now called irrigation) with water and caution twice daily for four days.  When successful this is one of the more satisfying procedures for a patient and therefore the operator. Traditionally wax has been softened with Sodium Bicarbonate or Olive Oil at [[fever|body temperature]] dripped into the ear (and the position with the canal pointing vertically upward maintained for 10 minutes) followed if necessary by syringing (now called irrigation) with water and caution twice daily for four days.  When successful this is one of the more satisfying procedures for a patient and therefore the operator. Line 28: Line 37: Various ad hoc techniques have been usedSupersoaker ear cannon. CMAJ  http://www.cmaj.ca/cgi/content/full/173/12/1496.  Ingenuity is valuable, but caution is paramount. Various ad hoc techniques have been usedSupersoaker ear cannon. CMAJ  http://www.cmaj.ca/cgi/content/full/173/12/1496.  Ingenuity is valuable, but caution is paramount.  +  +===UPDATE - US guidance on treating cerumen impaction===  +In January 2017 the American Academy of Otolaryngology updated its guidelines.[http://journals.sagepub.com/doi/10.1177/0194599816671491 Schwartz SR, Magit AE, Rosenfeld RM, Ballachanda BB, Hackell JM, Krouse HJ, et al. Clinical Practice Guideline (Update): Earwax (Cerumen Impaction). Otolaryngology-Head and Neck Surgery 2017;156(1_suppl):S1-S29. doi: 10.1177/0194599816671491.] These have been summarised by Louis Bell in [http://www.jwatch.org/na43260/2017/01/17/updated-guidelines-treating-cerumen-impaction NEJM JournalWatch] as follows:  +  +The American Academy of Otolaryngology-Head and Neck Surgery has updated its 2008 clinical practice guidelines on management of cerumen impaction.  +  +'''Sponsoring Organization:''' The American Academy of Otolaryngology-Head and Neck Surgery  +  +'''Target Audience:''' All clinicians likely to diagnose and manage patients with cerumen impaction  +  +'''Target Population:''' Patients older than 6 months  +  +'''Background and Objective'''  +  +Cerumen naturally migrates out of the ear canal assisted by jaw movement but may occlude or become impacted in the canal, sometimes causing hearing loss, tinnitus, itching, pain, or cough or impeding assessment of the tympanic membrane and middle ear structures. Cerumen impaction i[...]



Abbreviations

Tue, 17 Jan 2017 15:04:00 GMT

E:

← Older revision Revision as of 15:04, 17 January 2017
Line 265: Line 265:
*ERCP - [[Endoscopic retrograde cholangiopancreatogram]]
*ERCP - [[Endoscopic retrograde cholangiopancreatogram]]
*EPA - Enduring Power of Attorney - see [[Mental Capacity Act 2005]]
*EPA - Enduring Power of Attorney - see [[Mental Capacity Act 2005]]
 +
*EPAC - [[Pregnancy|Early Pregnancy Advisory Clinic]]
*EPP - [[Exposure-prone procedures|Exposure-prone procedure[s]]]
*EPP - [[Exposure-prone procedures|Exposure-prone procedure[s]]]
*ERPC - Evacuation of Retained Products of Conception
*ERPC - Evacuation of Retained Products of Conception



RNA-induced silencing complex

Mon, 16 Jan 2017 08:24:17 GMT

categorise

← Older revision Revision as of 08:24, 16 January 2017
Line 6: Line 6:
[[Category:Translation regulators]]
[[Category:Translation regulators]]
[[Category:Translation]]
[[Category:Translation]]
 +
[[Category:RNA]]



Small nuclear RNA

Mon, 16 Jan 2017 08:23:49 GMT

categorise

← Older revision Revision as of 08:23, 16 January 2017
Line 1: Line 1:
{{GeneticsBox}}
{{GeneticsBox}}
-
[[Category:Nucleic acids]]
+
[[Category:Nucleic acids]][[Category:RNA]]
[[Small nuclear RNA]] (smRNA) is [[RNA]] used in nuclear processes such as [[alternative splicing]] in the [[spliceosome]]s. Parts of smRNA will be used to pattern match other nucleic acid polymers, and some smRNAs appear to function  as [[ribozyme]]s.
[[Small nuclear RNA]] (smRNA) is [[RNA]] used in nuclear processes such as [[alternative splicing]] in the [[spliceosome]]s. Parts of smRNA will be used to pattern match other nucleic acid polymers, and some smRNAs appear to function  as [[ribozyme]]s.



SnRNA

Mon, 16 Jan 2017 08:22:41 GMT

redirect

New page

#redirect[[small nuclear RNA]]
[[Category:RNA]]



RNA interference

Mon, 16 Jan 2017 08:21:36 GMT

typos ← Older revision Revision as of 08:21, 16 January 2017 Line 19: Line 19: This is not necessarily just through degradation of mRNA as was originally thought from the easily studied shRNA model. There is increasing evidence that miRNAs regulate the [[:category:translation|translation]] of mRNA, perhaps in more than one way. This is not necessarily just through degradation of mRNA as was originally thought from the easily studied shRNA model. There is increasing evidence that miRNAs regulate the [[:category:translation|translation]] of mRNA, perhaps in more than one way. ===miRNA regulation=== ===miRNA regulation=== -Hundreds of regions within the human genome encode for miRNA genes. These are transcribed as usual primary transcripts by [[RNA polymerase II]] into pri-miRNA. This is processed to [[pre-microRNA]] ([[pre-miRNA]]) in the nucleus by the [[microprocessor complex]] of the nuclease [[Wikipedia:Drosha|Drosha]] and the double-stranded RNA binding protein [[Wikipedia:Pasha|Pasha]]. [[Exportin-5]] exports this from the cell nucleus and in the cytoplasm this is further processed by the endonuclease [[Endoribonuclease Dicer|Dicer]] to a siRNA and the active strand then acts with [[endoribonuclease Dicer]] and the [[RNA-induced silencing complex]] ([[RISK]]) to regulate mRNA transcription at the three prime untranslated region (3' UTR) of the mRNA. Multiple miRNAs may have activity on one mRNA and this helps explain some of the complexities of cell differentiation. In man miRNA can be a relatively blunt instrument, with one miRNA sometimes regulating multiple mRNA expression and indeed over [http://microrna.sanger.ac.uk/cgi-bin/targets/v4/hit_list.pl?genome_id=2964 37431 human genes] have been matched to over 470 native human miRNAs. Interestingly miRNA expression profiles appear to vary from tissue to tissue but are similar for identical tissues. They also change during differentiation with loss of some miRNA expression profiles the further you get from the stem cell. Brain subregions have distinct profiles and indeed almost 500 unique miRNAs have been identified related to the development (and functioning) of the primate brain[[Pubmed:17072315|Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, Cuppen E, et al. Diversity of microRNAs in human and chimpanzee brain. Nature genetics 2006;38:1375-7.]] ([http://dx.doi.org/10.1038/ng1914 Direct link] – subscription may be required.).   +Hundreds of regions within the human genome encode for miRNA genes. These are transcribed as usual primary transcripts by [[RNA polymerase II]] into pri-miRNA. This is processed to [[pre-microRNA]] ([[pre-miRNA]]) in the nucleus by the [[microprocessor complex]] of the nuclease [[Wikipedia:Drosha|Drosha]] and the double-stranded RNA binding protein [[Wikipedia:Pasha|Pasha]]. [[Exportin-5]] exports this from the cell nucleus and in the cytoplasm this is further processed by the endonuclease [[Endoribonuclease Dicer|Dicer]] to a siRNA and the active strand then acts with [[endoribonuclease Dicer]] and the [[RNA-induced silencing complex]] ([[RISC]]) to regulate mRNA transcription at the three prime untranslated region (3' UTR) of the mRNA. Multiple miRNAs may have activity on one mRNA and this helps explain some of the complexities of cell differentiation. In man miRNA can be a relatively blunt instrument, with one miRNA sometimes regulating multiple mRNA expression and indeed over [http://microrna.sanger.ac.uk/cgi-bin/targets/v4/hit_list.pl?genome_id=2964 37431 human genes] have been matched to over 470 native human miRNAs. Interestingly miRNA expression profiles appear to vary from tissue to tissue but are similar for identical tissues. They also change during differentiation with loss of some miRNA expression prof[...]



RNA induced silencing complex

Mon, 16 Jan 2017 08:19:33 GMT

redirect

New page

#redirect[[RNA-induced silencing complex]]



RISC-loading complex subunit TARBP2

Mon, 16 Jan 2017 08:18:46 GMT

function

← Older revision Revision as of 08:18, 16 January 2017
Line 10: Line 10:
#[[Spermatid perinuclear RNA-binding protein]]
#[[Spermatid perinuclear RNA-binding protein]]
#[[Transcription elongation factor A N-terminal and central domain-containing protein]]
#[[Transcription elongation factor A N-terminal and central domain-containing protein]]
 +
 +
It binds to the [[RNA]] of RNA containing viruses so helping to promote silencing of translation.



TARBP2

Mon, 16 Jan 2017 08:15:14 GMT

subclude

New page

{{GeneticsBox}}
[[Category:Genes]]
{{:RISC-loading complex subunit TARBP2}}



RISC-loading complex subunit TARBP2

Mon, 16 Jan 2017 08:14:33 GMT

it interacts with itself but this does not really count

New page


{{BiochemistryBox|||TAR RNA-binding protein 2, trans-activation-responsive RNA-binding protein}}
[[Category:Translation regulators]]

The [[TARBP2]] gene at 12q13.13 codes for the 366 amino acid [[RISC-loading complex subunit TARBP2]]. It has two isoforms produced by alternative promoter usage. [[RISC-loading complex subunit TARBP2]] is required for formation of the [[RNA induced silencing complex]] ([[RISC]]) which [[SiRNA]]s and [[miRNA]]s interact with to direct its function. In this context [[RISC]] refers to the trimeric RISC loading complex (RLC), or micro-RNA (miRNA) loading complex (miRLC) which contains [[endoribonuclease Dicer]], [[protein argonaute-2]] and [[RISC-loading complex subunit TARBP2]]. [[RISC-loading complex subunit TARBP2]] is one of the two proteins that preprocess and load RNA for [[protein argonaute-2]] which once primed can act on [[mRNA]] by itself with the siRNA in the minimal [[RISC]]. It has binary interactions with the following human proteins:
#[[Protein argonaute-2]]
#[[Interferon-inducible double-stranded RNA-dependent protein kinase activator A]]
#[[Interferon-induced, double-stranded RNA-activated protein kinase]]
#[[Zinc finger protein 346]]
#[[Spermatid perinuclear RNA-binding protein]]
#[[Transcription elongation factor A N-terminal and central domain-containing protein]]



RISK

Mon, 16 Jan 2017 08:06:28 GMT

deleted "[[RISK]]" content was: "{{disambig}} Category:Abbreviations *RNA-induced silencing complex in translation regulation by short interfering RNA *Multiple other "inventions" in jargon" (and the only contributor was "Mlj")




History of Medicine

Sun, 15 Jan 2017 22:31:25 GMT

update ← Older revision Revision as of 22:31, 15 January 2017 Line 143: Line 143:     -==Timeline: 1800 - 2010==+==Timeline: 1800 - 2100==
-*'''1800'''  [[Humphry Davy]] announces the anaesthetic properties of [[nitrous oxide]]+*'''[[1800]]'''  [[Humphry Davy]] announces the anaesthetic properties of [[nitrous oxide]] -*'''1816'''  [[Rene Laennec]] invents the [[stethoscope]]+*'''[[1816]]'''  [[Rene Laennec]] invents the [[stethoscope]] -*'''1842'''  [[Crawford Long]] performs the first surgical operation using [[anaesthesia]]+*'''[[1842]]'''  [[Crawford Long]] performs the first surgical operation using [[anaesthesia]] -*'''1847'''  [[Ignaz Semmelweis]] studies and prevents the transmission of [[puerperal fever]]+*'''[[1847]]'''  [[Ignaz Semmelweis]] studies and prevents the transmission of [[puerperal fever]] -*'''1870'''  [[Louis Pasteur]] and [[Robert Koch]] establish the [[germ theory]] of disease+*'''[[1870]]'''  [[Louis Pasteur]] and [[Robert Koch]] establish the [[germ theory]] of disease -*'''1881'''  [[Louis Pasteur]] develops an [[anthrax]] [[vaccine]]+*'''[[1881]]'''  [[Louis Pasteur]] develops an [[anthrax]] [[vaccine]] -*'''1882'''  [[Louis Pasteur]] develops a [[rabies]] vaccine+*'''[[1882]]'''  [[Louis Pasteur]] develops a [[rabies]] vaccine -*'''1882'''  [[Robert Koch]] discovers ''[[Mycobacterium tuberculosis]]''+*'''[[1882]]'''  [[Robert Koch]] discovers ''[[Mycobacterium tuberculosis]]'' -*'''1890'''  [[Emil von Behring]] discovers antitoxins and uses them to develop [[tetanus]] and [[diphtheria]] vaccines+*'''[[1890]]'''  [[Emil von Behring]] discovers antitoxins and uses them to develop [[tetanus]] and [[diphtheria]] vaccines -*'''1897'''  [[Aspirin]] the first completely synthetic drug (launched 1899)+*'''[[1897]]'''  [[Aspirin]] the first completely synthetic drug (launched 1899) -*'''1901'''  [[Karl Landsteiner]]'s first work on ABO grouping of blood - beginning the basis of [[transplantation]]+*'''[[1901]]'''  [[Karl Landsteiner]]'s first work on ABO grouping of blood - beginning the basis of [[transplantation]] -*'''1906'''  [[Frederick Hopkins]] suggests the existence of [[:category:vitamins|vitamins]] and suggests that a lack of vitamins causes [[scurvy]] and [[rickets]]+*'''[[1906]]'''  [[Frederick Hopkins]] suggests the existence of [[:category:vitamins|vitamins]] and suggests that a lack of vitamins causes [[scurvy]] and [[rickets]] -*'''1907'''  [[Paul Ehrlich]] develops a chemotherapeutic cure for [[sleeping sickness]]+*'''[[1907]]'''  [[Paul Ehrlich]] develops a chemotherapeutic cure for [[sleeping sickness]] -*'''1921'''  [[Edward Mellanby]] discovers vitamin D and shows that its absence causes [[rickets]]+*'''[[1921]]'''  [[Edward Mellanby]] discovers vitamin D and shows that its absence causes [[rickets]] -*'''1928'''  [[Alexander Fleming]] discovers [[:category:Penicillins|penicillin]]+*'''[[1928]]'''  [[Alexander Fleming]] discovers [[:category:Penicillins|penicillin]] -*'''1932'''  [[Gerhard Domagk]] develops a chemotherapeutic cure for streptococcus+*'''[[1932]]'''  [[Gerhard Domagk]] develops a chemotherapeutic cure for streptococcus -*'''1944'''  [[Oswald[...]



Talk:Main Page

Sun, 15 Jan 2017 20:57:20 GMT

update on memory leak that I monitored for some of today ← Older revision Revision as of 20:57, 15 January 2017 Line 169: Line 169: :::::::::::::Have been investigating memory leak in Apache. Assume its bad php. Have also blocked some attempts to get in via wordpress which we certainly have not got. Some of the wiki configuration after our 2012 upgrade/recovery is very suspicious and have amongst other minor changes reverted skins to correct mediawiki version but copied over KHTMLFixes which is the webkit horizontal scroll bar issue- bots seem to have been asking for lots of deep php files outside monobook which was only skin updated, see how long memory stays at about 652000k free max after this change ...any things worth a try[[User:Mlj|Mlj]] 19:21, 30 December 2016 (UTC) :::::::::::::Have been investigating memory leak in Apache. Assume its bad php. Have also blocked some attempts to get in via wordpress which we certainly have not got. Some of the wiki configuration after our 2012 upgrade/recovery is very suspicious and have amongst other minor changes reverted skins to correct mediawiki version but copied over KHTMLFixes which is the webkit horizontal scroll bar issue- bots seem to have been asking for lots of deep php files outside monobook which was only skin updated, see how long memory stays at about 652000k free max after this change ...any things worth a try[[User:Mlj|Mlj]] 19:21, 30 December 2016 (UTC) ::::::::::::::Still memory leak that fills it in days. Only reason no outage is that I have been able to reboot in good time over Xmas break. 07:42, 4 January 2017 (UTC) ::::::::::::::Still memory leak that fills it in days. Only reason no outage is that I have been able to reboot in good time over Xmas break. 07:42, 4 January 2017 (UTC)  +:::::::::::::::Memory leak continues. I managed to overload database connections forcing it to go into swap with just editing 25 odd pages fairly quickly with a template replacement at the same time it was being hit hard by an indexing bot that used up 700000k of memory in no time. Suspect some of my concurrent thread control has made a slight difference but it definitely does not like going into swap. [[User:Mlj|Mlj]] 20:57, 15 January 2017 (UTC) ==pubmed_caption_finder== ==pubmed_caption_finder== This has to be updated given PubMed's shift to https from tomorrow. From today it will generate https references BUT  the module still uses http call in php (as https call not recognised) to get all the info. This will no doubt change and give us message "Unable to contact Pubmed. This may be transient - please try again later. If this error recurs, please contact a ganfyd admin." If in due course I can enable php to do https I have version 20 of the module uploaded and ready to go and replace present version 21 (we were on version 19 before today) Cheers[[User:Mlj|Mlj]] 18:37, 26 September 2016 (BST) This has to be updated given PubMed's shift to https from tomorrow. From today it will generate https references BUT  the module still uses http call in php (as https call not recognised) to get all the info. This will no doubt change and give us message "Unable to contact Pubmed. This may be transient - please try again later. If this error recurs, please contact a ganfyd admin." If in due course I can enable php to do https I have version 20 of the module uploaded and ready to go and replace present version 21 (we were on version 19 before today) Cheers[[User:Mlj|Mlj]] 18:37, 26 September 2016 (BST) [...]



Indoleamine 2,3-dioxygenase 1

Sun, 15 Jan 2017 20:48:23 GMT

EC template

← Older revision Revision as of 20:48, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Indoleamine-pyrrole 2,3-dioxygenase, IDO-1, EC:1.13.11.52}}
+
{{BiochemistryBox|||Indoleamine-pyrrole 2,3-dioxygenase, IDO-1, {{EC|1.13.11.52}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Metabolism]]
[[Category:Metabolism]]
[[Category:Immunology]]
[[Category:Immunology]]
{{:IDO1}}
{{:IDO1}}



UDP-glucuronosyltransferase 2B10

Sun, 15 Jan 2017 20:47:57 GMT

EC template

← Older revision Revision as of 20:47, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||UDPGT 2B10, EC:2.4.1.17}}
+
{{BiochemistryBox|||UDPGT 2B10, {{EC|2.4.1.17}}}}
{{:UGT2B10}}
{{:UGT2B10}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Metabolism]]
[[Category:Metabolism]]



Glutamate decarboxylase 2

Sun, 15 Jan 2017 20:47:12 GMT

EC template

← Older revision Revision as of 20:47, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||65 kDa glutamic acid decarboxylase, glutamate decarboxylase 65 kDa isoform, GAD-65, EC:4.1.1.15}}
+
{{BiochemistryBox|||65 kDa glutamic acid decarboxylase, glutamate decarboxylase 65 kDa isoform, GAD-65, {{EC|4.1.1.15}}}}
[[category:enzymes]]
[[category:enzymes]]



Serine-protein kinase ATM

Sun, 15 Jan 2017 20:46:47 GMT

EC template

← Older revision Revision as of 20:46, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Ataxia telangiectasia mutated, A-T mutated, EC:2.7.11.1}}
+
{{BiochemistryBox|||Ataxia telangiectasia mutated, A-T mutated, {{EC|2.7.11.1}}}}
[[Category:Tumour suppressor proteins]]
[[Category:Tumour suppressor proteins]]
[[Category:protein kinases]]
[[Category:protein kinases]]
{{:ATM}}
{{:ATM}}



Glutamate decarboxylase 1

Sun, 15 Jan 2017 20:46:09 GMT

EC template

← Older revision Revision as of 20:46, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||67 kDa glutamic acid decarboxylase, glutamate decarboxylase 67 kDa isoform, brain glutamate decarboxylase, GAD-67, EC:4.1.1.15}}
+
{{BiochemistryBox|||67 kDa glutamic acid decarboxylase, glutamate decarboxylase 67 kDa isoform, brain glutamate decarboxylase, GAD-67, {{EC|4.1.1.15}}}}
[[category:enzymes]]
[[category:enzymes]]



Rab geranylgeranyltransferase

Sun, 15 Jan 2017 20:46:02 GMT

EC template

← Older revision Revision as of 20:46, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||GGTase, EC:2.5.1.60}}
+
{{BiochemistryBox|||GGTase, {{EC|2.5.1.60}}}}
This is a trimer enzyme complex that binds unprenylated [[Wikipedia:Rab (G-protein)|Rab proteins]] and undertakes the [[Wikipedia:Prenylation|prenylation]] geranylgeranyl transfer reaction. This is necessary for membrane association and target-protein recognition and if this post-translational modification does not occur Rab proteins cannot participate in pathways of intracellular vesicular transport. It is composed of:
This is a trimer enzyme complex that binds unprenylated [[Wikipedia:Rab (G-protein)|Rab proteins]] and undertakes the [[Wikipedia:Prenylation|prenylation]] geranylgeranyl transfer reaction. This is necessary for membrane association and target-protein recognition and if this post-translational modification does not occur Rab proteins cannot participate in pathways of intracellular vesicular transport. It is composed of:
#[[Geranylgeranyl transferase type-2 subunit alpha]]
#[[Geranylgeranyl transferase type-2 subunit alpha]]



Probable Xaa-Pro aminopeptidase 3

Sun, 15 Jan 2017 20:44:57 GMT

EC template

← Older revision Revision as of 20:44, 15 January 2017
Line 1: Line 1:
-
{{biochemistryBox|||X-Pro aminopeptidase 3, aminopeptidase P3, EC:3.4.11.9, APP3}}
+
{{biochemistryBox|||X-Pro aminopeptidase 3, aminopeptidase P3, {{EC|3.4.11.9}}, APP3}}
{{:XPNPEP3}}
{{:XPNPEP3}}
[[category:enzymes]]
[[category:enzymes]]
[[category:regulatory proteins]]
[[category:regulatory proteins]]



Circadian locomoter output cycles protein kaput

Sun, 15 Jan 2017 20:44:42 GMT

EC template

← Older revision Revision as of 20:44, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Class E basic helix-loop-helix protein 8, hCLOCK, bHLHe8, EC:2.3.1.48}}
+
{{BiochemistryBox|||Class E basic helix-loop-helix protein 8, hCLOCK, bHLHe8, {{EC|2.3.1.48}}}}
{{:CLOCK}}
{{:CLOCK}}
[[category:Transcriptional activators]]
[[category:Transcriptional activators]]



Receptor-interacting serine/threonine-protein kinase 1

Sun, 15 Jan 2017 20:44:27 GMT

EC template

← Older revision Revision as of 20:44, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Cell death protein RIP, receptor-interacting protein 1, serine/threonine-protein kinase RIP, RIP-1, EC:2.7.11.1}}
+
{{BiochemistryBox|||Cell death protein RIP, receptor-interacting protein 1, serine/threonine-protein kinase RIP, RIP-1, {{EC|2.7.11.1}}}}
[[category:Enzymes]]
[[category:Enzymes]]
[[Category:Regulatory proteins]]
[[Category:Regulatory proteins]]



Receptor-interacting serine/threonine-protein kinase 3

Sun, 15 Jan 2017 20:44:10 GMT

EC template

← Older revision Revision as of 20:44, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||RIP-like protein kinase 3, receptor-interacting protein 3, RIP-3, EC:2.7.11.1}}
+
{{BiochemistryBox|||RIP-like protein kinase 3, receptor-interacting protein 3, RIP-3, {{EC|2.7.11.1}}}}
[[Category:protein kinases]]
[[Category:protein kinases]]
[[Category:regulatory proteins]]
[[Category:regulatory proteins]]



Adenosine deaminase

Sun, 15 Jan 2017 20:43:07 GMT

EC template

← Older revision Revision as of 20:43, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Adenosine aminohydrolase, EC:3.5.4.4}}
+
{{BiochemistryBox|||Adenosine aminohydrolase, {{EC|3.5.4.4}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
{{:ADA}}
{{:ADA}}



Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating

Sun, 15 Jan 2017 20:40:57 GMT

EC template

← Older revision Revision as of 20:40, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Decarboxylating sterol-4-alpha-carboxylate 3-dehydrogenase, Protein H105e3, EC:1.1.1.170}}
+
{{BiochemistryBox|||Decarboxylating sterol-4-alpha-carboxylate 3-dehydrogenase, Protein H105e3, {{EC|1.1.1.170}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Lipid metabolism]]
[[Category:Lipid metabolism]]
[[Category:Cholesterol metabolism]]
[[Category:Cholesterol metabolism]]
{{:NSDHL}}
{{:NSDHL}}



Cyclin-dependent kinase 6

Sun, 15 Jan 2017 20:40:40 GMT

EC template

← Older revision Revision as of 20:40, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Cell division protein kinase 6, serine/threonine-protein kinase PLSTIRE, EC:2.7.11.22}}
+
{{BiochemistryBox|||Cell division protein kinase 6, serine/threonine-protein kinase PLSTIRE, {{EC|2.7.11.22}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Regulatory proteins]]
[[Category:Regulatory proteins]]



Fatty-acid amide hydrolase 2

Sun, 15 Jan 2017 20:40:27 GMT

EC template

← Older revision Revision as of 20:40, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Amidase domain-containing protein, anandamide amidohydrolase 2, oleamide hydrolase 2, EC:3.5.1.99}}
+
{{BiochemistryBox|||Amidase domain-containing protein, anandamide amidohydrolase 2, oleamide hydrolase 2, {{EC|3.5.1.99}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]



Monoglyceride lipase

Sun, 15 Jan 2017 20:40:08 GMT

typo

← Older revision Revision as of 20:40, 15 January 2017
(One intermediate revision not shown)
Line 1: Line 1:
-
{{BiochemistryBox|||monoacylglycerol lipase, lysophospholipase homolog, lysophospholipase-like monoacylglycerol lipase, EC:3.1.1.23, MGL, HU-K51}}
+
{{BiochemistryBox|||monoacylglycerol lipase, lysophospholipase homolog, lysophospholipase-like monoacylglycerol lipase, {{EC|3.1.1.23}}, MGL, HU-K51}}
[[Category:Enzymes]]
[[Category:Enzymes]]
The [[MGLL]] gene at  3q21.3 codes for the propeptide of [[monoglyceride lipase]]. This converts monoacylglycerides to free fatty acids and glycerol. By hydrolysing the [[:category:endocannabinoids|endocannabinoid]] [[2-arachidonoylglycerol]], it is key to the regulation of endocannabinoid signaling and nociperception. Cancer cell migration, invasion and tumour growth are modulated by it.
The [[MGLL]] gene at  3q21.3 codes for the propeptide of [[monoglyceride lipase]]. This converts monoacylglycerides to free fatty acids and glycerol. By hydrolysing the [[:category:endocannabinoids|endocannabinoid]] [[2-arachidonoylglycerol]], it is key to the regulation of endocannabinoid signaling and nociperception. Cancer cell migration, invasion and tumour growth are modulated by it.



Fatty-acid amide hydrolase 1

Sun, 15 Jan 2017 20:39:29 GMT

EC template ← Older revision Revision as of 20:39, 15 January 2017 Line 1: Line 1: -{{BiochemistryBox|||Anandamide amidohydrolase 1, oleamide hydrolase 1, EC:3.5.1.99}}+{{BiochemistryBox|||Anandamide amidohydrolase 1, oleamide hydrolase 1, {{EC|3.5.1.99}}}} The [[FAAH]] gene at 1p33 with 15 exons codes for the 579 amino acid pro-peptide to [[fatty-acid amide hydrolase 1]]. The peptide has specific properties compared to other similar enzymes that allows it to integrate into [[cell membrane]]s and establish direct access to the bilayer from its active site. It is one of the two human [[fatty acid amide hydrolase]]s (some mammals like mice and rats only have one) that degrade the signalling bioactive fatty acid amides like the endogenous cannabinoid, [[anandamide]]. Inhibitors are under active development as neurones using such signalling appear to central to a number of perceptions and have pain depressant, antidepressant and/or anxiolytic-like activity. The enteric nervous system's myenteric plexus regulation of gut transit times and other intestinal function also appears to depend upon these enzymes. Genetic variation may be important in some personality traits. The [[FAAH]] gene at 1p33 with 15 exons codes for the 579 amino acid pro-peptide to [[fatty-acid amide hydrolase 1]]. The peptide has specific properties compared to other similar enzymes that allows it to integrate into [[cell membrane]]s and establish direct access to the bilayer from its active site. It is one of the two human [[fatty acid amide hydrolase]]s (some mammals like mice and rats only have one) that degrade the signalling bioactive fatty acid amides like the endogenous cannabinoid, [[anandamide]]. Inhibitors are under active development as neurones using such signalling appear to central to a number of perceptions and have pain depressant, antidepressant and/or anxiolytic-like activity. The enteric nervous system's myenteric plexus regulation of gut transit times and other intestinal function also appears to depend upon these enzymes. Genetic variation may be important in some personality traits. [...]



Cytoplasmic NADP isocitrate dehydrogenase

Sun, 15 Jan 2017 20:39:22 GMT

EC template

← Older revision Revision as of 20:39, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox||Isocitrate dehydrogenase|Isocitrate dehydrogenase [NADP], cytoplasmic, oxalosuccinate decarboxylase, cytosolic NADP-isocitrate dehydrogenase, NADP(+)-specific ICDH, IDH, ICD-M, IDP, PICD, EC:1.1.1.42}}
+
{{BiochemistryBox||Isocitrate dehydrogenase|Isocitrate dehydrogenase [NADP], cytoplasmic, oxalosuccinate decarboxylase, cytosolic NADP-isocitrate dehydrogenase, NADP(+)-specific ICDH, IDH, ICD-M, IDP, PICD, {{EC|1.1.1.42}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]



Succinate dehydrogenase complex subunit B

Sun, 15 Jan 2017 20:39:02 GMT

EC template

← Older revision Revision as of 20:39, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Mitochondrial succinate dehydrogenase [ubiquinone] iron-sulfur subunit, iron-sulfur subunit of complex II, iron-sulphur subunit of complex II, EC:1.3.5.1, Ip}}
+
{{BiochemistryBox|||Mitochondrial succinate dehydrogenase [ubiquinone] iron-sulfur subunit, iron-sulfur subunit of complex II, iron-sulphur subunit of complex II, {{EC|1.3.5.1}}, Ip}}
[[Category:Enzymes]]
[[Category:Enzymes]]
{{:SDHB}}
{{:SDHB}}



Succinate dehydrogenase complex subunit A

Sun, 15 Jan 2017 20:38:50 GMT

EC template

← Older revision Revision as of 20:38, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||mitochondrial succinate dehydrogenase [ubiquinone] flavoprotein subunit, flavoprotein subunit of complex II, EC:1.3.5.1, Fp}}
+
{{BiochemistryBox|||mitochondrial succinate dehydrogenase [ubiquinone] flavoprotein subunit, flavoprotein subunit of complex II, {{EC|1.3.5.1}}, Fp}}
[[Category:Enzymes]]
[[Category:Enzymes]]
{{:SDHA}}
{{:SDHA}}



Fumarate hydratase

Sun, 15 Jan 2017 20:38:12 GMT

EC template

← Older revision Revision as of 20:38, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||mitochondrial fumarate hydratase, fumarase, EC:4.2.1.2}}
+
{{BiochemistryBox|||mitochondrial fumarate hydratase, fumarase, {{EC|4.2.1.2}}}}
[[Category: Enzymes]]
[[Category: Enzymes]]
[[Category:Tumour suppressor proteins]]
[[Category:Tumour suppressor proteins]]



Alpha-N-acetylglucosaminidase

Sun, 15 Jan 2017 20:36:58 GMT

EC template

← Older revision Revision as of 20:36, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||N-acetyl-alpha-glucosaminidase,  N-acetyl-alpha-D-glucosaminidase, alpha-D-2-acetamido-2-deoxyglucosidase, NAG, EC:3.2.1.50}}
+
{{BiochemistryBox|||N-acetyl-alpha-glucosaminidase,  N-acetyl-alpha-D-glucosaminidase, alpha-D-2-acetamido-2-deoxyglucosidase, NAG, {{EC|3.2.1.50}}}}
[[category:enzymes]]
[[category:enzymes]]
{{:Mucopolysaccharidosis IIIB}}
{{:Mucopolysaccharidosis IIIB}}



Heparan-alpha-glucosaminide N-acetyltransferase

Sun, 15 Jan 2017 20:36:34 GMT

EC template

← Older revision Revision as of 20:36, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Transmembrane protein 76, acetyl-CoA:heparan-α-D-glucosaminide N-acetyltransferase, acetyl-CoA:alpha-glucosaminide N-acetyltransferase, EC:2.3.1.78}}
+
{{BiochemistryBox|||Transmembrane protein 76, acetyl-CoA:heparan-α-D-glucosaminide N-acetyltransferase, acetyl-CoA:alpha-glucosaminide N-acetyltransferase, {{EC|2.3.1.78}}}}
[[category:enzymes]]
[[category:enzymes]]
{{:Mucopolysaccharidosis IIIC}}
{{:Mucopolysaccharidosis IIIC}}



N-acetylglucosamine-6-sulfatase

Sun, 15 Jan 2017 20:36:27 GMT

EC template

← Older revision Revision as of 20:36, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Glucosamine-6-sulfatase,  glucosamine (N-acetyl)-6-sulfatase,  N-acetylglucosamine-G-sulfate sulfatase, glucosamine-6-sulphatase, G6S ,EC:3.1.6.14)}}
+
{{BiochemistryBox|||Glucosamine-6-sulfatase,  glucosamine (N-acetyl)-6-sulfatase,  N-acetylglucosamine-G-sulfate sulfatase, glucosamine-6-sulphatase, G6S , {{EC|3.1.6.14}}}}
[[category:Enzymes]]
[[category:Enzymes]]
{{:Mucopolysaccharidosis IIID}}
{{:Mucopolysaccharidosis IIID}}



Alpha-ketoglutarate-dependent dioxygenase FTO

Sun, 15 Jan 2017 20:35:47 GMT

EC template

← Older revision Revision as of 20:35, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Fat mass and obesity-associated protein, EC:1.14.11.-}}
+
{{BiochemistryBox|||Fat mass and obesity-associated protein, {{EC|1.14.11.-}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Regulatory proteins]]
[[Category:Regulatory proteins]]
{{:FTO}}
{{:FTO}}



ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1

Sun, 15 Jan 2017 20:35:29 GMT

EC template

← Older revision Revision as of 20:35, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||2'-phospho-ADP-ribosyl cyclase,  2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase 1, Cyclic ADP-ribose hydrolase 1, EC:2.4.99.20, ADPRC 1, cADPr hydrolase 1, T10, CD38}}
+
{{BiochemistryBox|||2'-phospho-ADP-ribosyl cyclase,  2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase 1, Cyclic ADP-ribose hydrolase 1, {{EC|2.4.99.20}}, ADPRC 1, cADPr hydrolase 1, T10, CD38}}
{{:CD38}}
{{:CD38}}
[[Category:Receptor proteins]]
[[Category:Receptor proteins]]
[[Category:Membrane proteins]]
[[Category:Membrane proteins]]



Breakpoint cluster region protein

Sun, 15 Jan 2017 20:35:13 GMT

EC template

← Older revision Revision as of 20:35, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Renal carcinoma antigen NY-REN-26, EC:2.7.11.1}}
+
{{BiochemistryBox|||Renal carcinoma antigen NY-REN-26, {{EC|2.7.11.1}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Tyrosine kinases]]
[[Category:Tyrosine kinases]]
[[Category:Regulatory proteins]]
[[Category:Regulatory proteins]]
{{:BCR}}
{{:BCR}}



Leucine-rich repeat kinase-2

Sun, 15 Jan 2017 20:34:57 GMT

EC template

← Older revision Revision as of 20:34, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Leucine-rich repeat serine/threonine-protein kinase 2, dardarin, EC:2.7.11.1}}
+
{{BiochemistryBox|||Leucine-rich repeat serine/threonine-protein kinase 2, dardarin, {{EC|2.7.11.1}}}}
[[category:Enzymes]]
[[category:Enzymes]]
{{:LRRK2}}
{{:LRRK2}}
[[Category:Serine kinases]]
[[Category:Serine kinases]]



E3 ubiquitin-protein ligase parkin

Sun, 15 Jan 2017 20:34:38 GMT

EC template

← Older revision Revision as of 20:34, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Parkin, Parkinson juvenile disease protein 2, Parkinson disease protein 2, EC:6.3.2.-}}
+
{{BiochemistryBox|||Parkin, Parkinson juvenile disease protein 2, Parkinson disease protein 2, {{EC|6.3.2.-}}}}
[[Category:enzymes]]
[[Category:enzymes]]



Mitochondrial serine/threonine-protein kinase PINK1

Sun, 15 Jan 2017 20:34:21 GMT

EC template

← Older revision Revision as of 20:34, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||PTEN-induced putative kinase protein 1, BRPK,EC:2.7.11.1}}
+
{{BiochemistryBox|||PTEN-induced putative kinase protein 1, BRPK, {{EC|2.7.11.1}}}}
{{:PINK1}}
{{:PINK1}}
[[Category:Enzymes]]
[[Category:Enzymes]]



Mitochondrial NADP isocitrate dehydrogenase

Sun, 15 Jan 2017 20:34:03 GMT

EC template

← Older revision Revision as of 20:34, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox||Isocitrate dehydrogenase|Isocitrate dehydrogenase [NADP], mitochondrial, oxalosuccinate decarboxylase, NADP(+)-specific ICDH,  IDH, ICD-M, IDP, EC:1.1.1.42}}
+
{{BiochemistryBox||Isocitrate dehydrogenase|Isocitrate dehydrogenase [NADP], mitochondrial, oxalosuccinate decarboxylase, NADP(+)-specific ICDH,  IDH, ICD-M, IDP, {{EC|1.1.1.42}}}}
[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Mitochondrial proteins]]
[[Category:Mitochondrial proteins]]



Acetyl-CoA acetyltransferase, mitochondrial

Sun, 15 Jan 2017 20:32:41 GMT

EC template

← Older revision Revision as of 20:32, 15 January 2017
Line 1: Line 1:
-
{{BiochemistryBox|||Mitochondrial acetoacetyl-CoA thiolase, mitochondrial, acetoacetyl-CoA thiolase, beta-ketothiolase, T2, EC:2.3.1.9}}
+
{{BiochemistryBox|||Mitochondrial acetoacetyl-CoA thiolase, mitochondrial, acetoacetyl-CoA thiolase, beta-ketothiolase, T2, {{EC|2.3.1.9}}}}
{{:ACAT1}}
{{:ACAT1}}
[[Category:Enzymes]]
[[Category:Enzymes]]